Mammalian metabolites of a tachykinin receptor antagonist

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/535 (2006.01) A61K 31/09 (2006.01) A61K 31/121 (2006.01) A61K 31/165 (2006.01) A61K 31/192 (2006.01) A61K 31/5375 (2006.01) C07C 43/315 (2006.01) C07C 45/28 (2006.01) C07C 45/64 (2006.01) C07C 45/71 (2006.01) C07C 49/255 (2006.01) C07C 49/84 (2006.01) C07C 59/88 (2006.01) C07C 59/90 (2006.01) C07D 265/32 (2006.01) C07D 265/33 (2006.01) C07D 405/06 (2006.01)

Patent

CA 2425908

This invention is concerned with mammalian metabolites of the compound 2-(R)- (1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)-phenyl-4-(3-(5- oxo-1H,4H-1,2,4-triazolo)methylmorpholine which is a tachykinin receptor antagonist that is useful in the prevention and treatment of certain disorders, including emesis and psychiatric disorders such as depression and anxiety.

L'invention concerne des métabolites mammifères du composé 2-(R)-(1-(R)-(3,5-bis(trifluorométhyl)phényl)éthoxy)-3-(S)-(4-fluoro)-phényl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)méthylmorpholine, lequel est un antagoniste du récepteur de la tachykinine utile dans le prévention et le traitement de certains troubles, notamment le vomissement et les troubles psychiatriques tels que la dépression et l'anxiété.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mammalian metabolites of a tachykinin receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mammalian metabolites of a tachykinin receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian metabolites of a tachykinin receptor antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1763170

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.